Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
CONTEXT: Levothyroxine monotherapy is the treatment of choice for hypothyroid patients because peripheral T4 to T3 conversion is believed to account for the overall tissue requirement for thyroid hormones. However, there are indirect evidences that this may not be the case in all patients. OBJECTIVE: To evaluate in a large series of athyreotic patients whether levothyroxine monotherapy can normalize serum thyroid hormones and thyroid-pituitary feedback. DESIGN: Retrospective study. SETTING: Academic hospital. PATIENTS: 1,811 athyreotic patients with normal TSH levels under levothyroxine monotherapy and 3,875 euthyroid controls. MEASUREMENTS: TSH, FT4 and FT3 concentrations by immunoassays. RESULTS: FT4 levels were significantly higher and FT3 levels were significantly lower (p<0.001 in both cases) in levothyroxine-treated athyreotic patients than in matched euthyroid controls. Among the levothyroxine-treated patients 15.2% had lower serum FT3 and 7.2% had higher serum FT4 compared to euthyroid controls. A wide range of FT3/FT4 ratios indicated a major heterogeneity in the peripheral T3 production capacity in different individuals. The correlation between thyroid hormones and serum TSH levels indicated an abnormal feedback mechanism in levothyroxine-treated patients. CONCLUSIONS: Athyreotic patients have a highly heterogeneous T3 production capacity from orally administered levothyroxine. More than 20% of these patients, despite normal TSH levels, do not maintain FT3 or FT4 values in the reference range, reflecting the inadequacy of peripheral deiodination to compensate for the absent T3 secretion. The long-term effects of chronic tissue exposure to abnormal T3/T4 ratio are unknown but a sensitive marker of target organ response to thyroid hormones (serum TSH) suggests that this condition causes an abnormal pituitary response. A more physiological treatment than levothyroxine monotherapy may be required in some hypothyroid patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These changes are an increase in T4 or free T4 (fT4) levels, an increase in fT4/T3 ratios, associated with a decline in T3 or free T3 (fT3) levels.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, in children and adults with an intact HPT axis, fT3 levels do not correlate with TSH levels (and in children they show a positive rather than the negative correlation seen with fT4) (11,87).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, low FT3 and an increased FT4/FT3 ratio after thyroidectomy has been reported in about 15% of a large unselected population (102).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lean body mass is not the only variable to estimate the therapeutic post-thyroidectomy LT4 dose, owing to the disappearance of thyroidal contribution to circulating T3 (102).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, Levothyroxine affects the T3:T4 ratio and individuals on levothyroxine have relatively low FT3: FT4 ratios [110].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [110]
Experimental — accuracy not yet measured
32 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853 · cited 1×
“he insufficient T3 peripheral production cannot be appropriately corrected by increasing levothyroxine dose because the inhibitory effect of elevated T4 on type II deiodinase [27,28] will end up increasing the imbalance of the circulating FT3/FT4 ratio (Figure 3).”
Deiodinases: implications of the local control of thyroid hormone action
Bianco, A. C., & Kim, B. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29812 · Cited by 845
Selenium, the Thyroid, and the Endocrine System
Köhrle, J., Jakob, F., Contempré, B., & Dumont, J. E. (2005) · Endocrine Reviews · doi:10.1210/er.2001-0034 · Cited by 529 · cited 1×
“function [23,24,25] and also abnormal thyroid hormone metabolism independent from deiodination [26].”
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 2×
“Their condition may ameliorate under a combined T4-T3 treatment [1,18,19,20].”
Zulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 338 · cited 1×
“secreted TSH may not reflect what happens in other target tissues and, therefore, in some instances serum TSH may not be an appropriate indicator of peripheral tissue euthyroidism [7,8,9].”
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327 · cited 1×
“Their condition may ameliorate under a combined T4-T3 treatment [1,18,19,20].”
Wekking, E. M., Appelhof, B. C., Fliers, E., Schene, A. H., Huyser, J., Tijssen, J. G. P., & Wiersinga, W. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02025 · Cited by 299 · cited 1×
“It should be underlined, however, that no long-term study is available to assess that the abnormal circulating thyroid hormone ratio has no adverse effect and that even short-term studies indicate that some hypothyroid patients do not reach a condition of well-being and emotional satisfaction under levothyroxine monot…”
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296 · cited 2×
“general well-being under levothyroxine monotherapy and (iii) that in many studies a short period of T4-T3 combination therapy has not caused a significant improvement in a variety of symptoms, the conclusion has been drown that levothyroxine monotherapy must be the standard treatment for all hypothyroid patients [16].”
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287 · cited 3×
“The major source of T3 within peripheral tissues comes from the circulating T3 pool and the variable portion coming from locally deiodinated T4 within each tissue might be not adequate according to animal experiments [5].”
Cited by
Items 201–300 of 307
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies
Deguchi-Horiuchi, H., Ito, M., Takahashi, S., Kousaka, K., Hisakado, M., Fukata, S., Kudo, T., Nishihara, E., Nishikawa, M., Miyauchi, A., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0497 · Cited by 3
How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?
Heald, A. H., Premawardhana, L. D. K. E., Taylor, P. N., Baker, A. R., Chaudhury, N., Fryer, A. A., Okosieme, O. E., Dayan, C. M., & Stedman, M. (2024) · Clinical Endocrinology · doi:10.1111/cen.15185 · Cited by 3
Jeon, M. J., Lee, S. H., Lee, J. J., Han, M. K., Kim, H., Kim, W. G., Kim, T. Y., Kim, W. B., Shong, Y. K., & Ryu, J. (2019) · International Journal of Thyroidology · doi:10.11106/ijt.2019.12.1.28 · Cited by 2
The Concept of Cure in Thyroid Diseases
Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.102269 · Cited by 3
“Levothyroxine replacement may cause disruption in psychological condition, lower resting energy expenditure, lower T3:T4 ratio, higher body mass index (BMI) and increased levels of serum cholesterol and LDL compared with normal controls (13-17).”
BackgroundSolter, D., & Solter, M. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.11.001 · Cited by 7
Challenges in replacement therapy of hypothyroidism: everyday practice and perspectives
Fadeyev, V. V. (2012) · Clinical and experimental thyroidology · doi:10.14341/ket20128317-29 · Cited by 5
“Представляет интерес тот факт, что когда пациентов и контрольную группу разделили на под группы в зависимости от уровня ТТГ, то в этих под группах (как при относительно низком, так и при от носительно высоком ТТГ) уровень Т3 был ниже у лиц, получающих L T4 [11].”
Nock, S., Höfig, C. S., Harder, L., Schomburg, L., Brabant, G. E., & Mittag, J. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1012-8484 · Cited by 5
“Interestingly, the gradient between TSH and fT3 increased with the dose of L-T4, indicating that TSH may not be sufficient for assessing euthyroidism [19, 20].”
BackgroundSakr, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-48775-1_10 · Cited by 4
Russo, M., Gullo, D., Tumino, D., Leonardi, D., Malandrino, P., & Frasca, F. (2022) · Clinical Endocrinology · doi:10.1111/cen.14738 · Cited by 3
“ubiquitination cannot be excluded in TP patients because the FT4/ TSH correlation curve displays a lower slope than EU subjects.(11) This hypothesis is reinforced by the observation that, at variance with EU”
MethodResultSelf-citationRolle der bioidenten Schilddrüsenhormone in der Behandlung der Hypothyreose: Ein Update
WEISSEL, M. (2019) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-019-0071-x · Cited by 3
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Porcelli, T., & Salvatore, D. (2020) · Endocrine · doi:10.1007/s12020-020-02391-5 · Cited by 3
Post-Radioiodine Graves' Management: The Pragma-Study
Perros, P., Dayan, C. M., Vaidya, B., Williams, G. R., Lazarus, J. H., Hickey, J., Willis, D., Archer, N., Franklyn, J. A., & Basu, A. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.44.oc3.3 · Cited by 3
Ito, M., Deguchi-Horiuchi, H., Takahashi, S., Hisakado, M., Kohsaka, K., Nishihara, E., Fukata, S., Nishikawa, M., Miyauchi, A., & Akamizu, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0259 · Cited by 2
Mazza, A. D. (2025) · Cureus · doi:10.7759/cureus.90685 · Cited by 9
Hoang, T. D., Patel, A. A., Spiro, A. J., Watson, N. L., & Shakir, M. K. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.09.007 · Cited by 2
Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism
Zielinski, R., Sacco, S. J., Dillon, M., Katsetos, M., & Celi, F. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1847857 · Cited by 2
A Deiodinase 2 Polymorphism May Lower Serum T 3 and Tissue T 3 in Levothyroxine-Treated Patients
Hershman, J. M. (2017) · Clinical Thyroidology · doi:10.1089/ct.2017;29.338-340 · Cited by 2
Study of Therapeutic Response on Variable Levothyroxine Supplementation in Hypothyroidism
(2018) · International Journal of Clinical Chemistry and Laboratory Medicine · doi:10.20431/2455-7153.0402005 · Cited by 1
Liothyronine use in primary hypothyroidism — current concepts
Concepción‐Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz‐Ibarra, J., Fernández-Dávila, F. V., Condori, D. C. D.-G., Rivera-Fabián, K., Herrera-Cabezas, R. G., & Urteaga, L. A. C. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0093 · Cited by 4
“Depending on the study, mean serum T3 or FT3 levels may be in the lower half of the normal range, and levels may even be below the normal range in up to 15% of individuals [15, 29, 30, 31].”
Joshi, A. M., Yadav, R. A., Shrestha, S., & Shrestha, J. (2021) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2021.7405 · Cited by 3
Caron, P. J. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.05.005 · Cited by 2
Jonklaas, J. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2492789 · Cited by 2
Azizi, F., Amouzegar, A., Abdi, H., Tohidi, M., Masoumi, S., Khalili, D., Mehrabi, Y., Zadeh–Vakili, A., Hedayati, M., Momenan, A. A., et al. (2025) · Trials · doi:10.1186/s13063-025-08940-5 · Cited by 3
Ivkovic, S. (2012) · European Thyroid Journal · doi:10.1159/000337977 · Cited by 2
Limitations of current thyroid function tests
García-Mayor, R. V. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.05.006 · Cited by 3
Peter, F., Muzsnai, Á., & Gráf, R. (2013) · InTech eBooks · doi:10.5772/54660 · Cited by 1
Hadi, Z. M., Alidrisi, H. A., & Mansour, A. A. (2024) · Cureus · doi:10.7759/cureus.58370 · Cited by 4
“The serum T3 levels in LT4-treated patients were low in numerous cross-sectional investigations evaluating the efficacy of therapy in patients with hypothyroidism [19].”
BackgroundAhmed, Z., Sherin, R. P. V., Fonseca, T. L., Hoang, T. D., & Shakir, M. K. M. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5651 · Cited by 2
Tsanava, I. A., Bulgakova, S. V., & Melikova, A. V. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-5-261-265 · Cited by 1
Is euthyroidism within reach for all?
Jonklaas, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267120 · Cited by 2
Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy
Baran, J. A., Isaza, A. R., Bojarsky, M., Alzoebie, L., Song, M., Halada, S., Sisko, L., Gonzales, S., Mostoufi‐Moab, S., & Bauer, A. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1443394 · Cited by 1
“Our fi ndings corroborate previous studies evaluating the ef fi cacy of LT 4 monotherapy to achieve normal T3 levels in the treatment of post-TT hypothyroidism in the adult population (8).”
BackgroundResultInfluentialRefractory hypothyroidism in children: an overview
Metwalley, K. A., & Farghaly, H. S. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0306 · Cited by 2
“This implies that T4 monotherapy may not be as bene fi cial in these patients as combined treat-ment with LT4 and T3 [57].”
Advances in hypothyroidism management: rethinking therapy beyond levothyroxine
Ditshego, R., Pick, J., & Ncube, K. N. (2025) · SA pharmaceutical journal. · doi:10.36303/sapj.3267 · Cited by 1
Bartalena, L., Gallo, D., Piantanida, E., & Tanda, M. L. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2676876 · Cited by 1
“In a study of 1181 athyreotic patients with normal serum TSH values under LT4 treatment, about 15% of patients had serum free T3 (FT3) below the normal range, while 7% had serum FT4 values above the upper normal range, with a resulting decrease in the FT3/FT4 ratio [153].”
Combined l-thyroxine and l-triiodothyronine replacement therapy in congenital hypothyroidism
Peter, F., & Muzsnai, Á. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29599 · Cited by 1
Low serum free thyroxine level in a girl with McCune-Albright syndrome
Roosimaa, M., Pajuväli, A., Peet, A., & Tillmann, V. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-206497 · Cited by 1
Terapia sostitutiva combinata con L-T4 e L-T3 nell’ipotiroidismo
Biondi, B., Celi, F. S., Duntas, L. H., Isidori, A. M., Pontecorvi, A., Salvatore, D., Vitti, P., & Trimarchi, F. (2015) · L Endocrinologo · doi:10.1007/s40619-015-0158-6 · Cited by 1
“Sebbene non ci siano evidenze sulla superiorità della terapia combinata verso la monoterapia con L-T4, alcuni risultati disponibili in letteratura, seppure non conclusivi, potrebbero suggerire un miglioramento della qualità di vita della terapia combinata soprattutto nei pazienti atireotici, poiché in tali pazienti la…”
BackgroundIntegrative Approaches to Patients Undergoing Thyroid Surgery
Olson, B. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-43618-0_23 · Cited by 2
Wilson’s Syndrome (Low T3 Syndrome)
Tang, C. J., & Garber, J. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_21 · Cited by 1
Nygaard, B. (2022) · doi:10.1093/med/9780198870197.003.0072 · Cited by 1
Levothyroxine may not adequately prepare hypothyroid women for controlled ovarian hyperstimulation
Bradbury, R. A., Byth, K., & Smith, H. C. (2024) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13854 · Cited by 1
Combined LT3 and LT4 therapy for precision medicine: easier with TTCombo system
Gatta, E., Ippolito, S., & Cappelli, C. (2024) · Endocrine · doi:10.1007/s12020-024-04084-9 · Cited by 1
Azizi, F., Moeini, A. S. H., Mehran, L., Masoumi, S., Abdi, H., Foroutan, S. M., Saghafinia, A. E., & Amouzegar, A. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100395 · Cited by 4
“In addition, studies in patients treated with LT4 monotherapy have shown alterations in resting energy expenditure, psychological well-being, body weight, and serum lipid concentrations, as well as lower serum T3 concentrations and a lower T3/T4 ratio compared to control individuals [8,10 – 14].”
Piva, I. R., Barollo, S., Censi, S., Bertazza, L., Ruggeri, E., Clausi, C., Ferrara, A. M., Stefani, A., Mion, M. M., Montagnana, M., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120354 · Cited by 1
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
“Post-thyroidectomy, TSHT4Rx leaves them with much lower FT3 levels than controls (210).”
Importance of Thyroid Hormone Replacement Therapy in Patients with Medullary Thyroid Cancer
Jonklaas, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39412-1_13 · Cited by 2
Elfayoumy, K. N., Elgazzar, U. B., Abo-alabbas, M. M., & Al-Adl, A. S. (2017) · Electronic physician · doi:10.19082/3706 · Cited by 1
“This study revealed significant increase in FT3/FT4 ratio which is an indicator of increased peripheral deiodination (30).”
BackgroundGarcía-Mayor, R. V. (2019) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.01.006 · Cited by 1
Temple, L. M., & Saigal, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00034-7 · Cited by 1
Returning to a Patient-Centered Approach in the Management of Hypothyroidism
Schneiderhan, J. R., & Zick, S. M. (2020) · The Annals of Family Medicine · doi:10.1370/afm.2602 · Cited by 1
The acute myxedema after hyperthyroidism treated by radioactive iodine and its sequelae
Ivkovic, S. (2013) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1349042i
Is the Replacement Dose of Levothyroxine Affected By the Presence of the Thyroid Gland?
Orgiazzi, J. (2015) · Clinical Thyroidology · doi:10.1089/ct.2015;27.205-208
Il controllo della concentrazione plasmatica degli ormoni tiroidei: cosa c’è di nuovo per la clinica
Porcelli, T., Alfano, F., & Dentice, M. (2014) · L Endocrinologo · doi:10.1007/s40619-014-0067-0
Optimal Management of Hypothyroidism: Incremental Improvements for use in 2016 and Beyond
Hennessey, J. V. (2016) · Endocrine Practice · doi:10.4158/ep161586.co
Leung, A. M. (2017) · Clinical Thyroidology · doi:10.1089/ct.2017;29.280-282
Thyroid Disease in Ageing and Risk Factors
Akbar, S., & Prasad, B. V. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-3480-8.ch019
Endocrine Disorders: Integrative Treatments of Hypothyroidism, Diabetes, and Adrenal Dysfunction
Yang, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190466268.003.0014
Solter, D., & Solter, M. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.11.003
García-Mayor, R. V. (2018) · Revista Clínica Española · doi:10.1016/j.rce.2018.10.007
Limitations of current thyroid function tests
García-Mayor, R. V. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.08.013 · Cited by 1
Thyroid Hormone Replacement: An Interim Era
Rutecki, G. W. (2016)
Analytical discrepancies and their potential impact on biomarkers and precision medicine initiative
Halim, A. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816121-0.00010-6
Leow, M. K. S. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/137045
Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels
Celi, F. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_26
Thyroid hormone, thyroid medication, and the skeleton
Freudenthal, B., Watts, L., Bassett, J. H. D., & Williams, G. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00046-0
Terapia sostitutiva tiroidea e risposta tissutale: quando il TSH non basta
Monzani, M. L., Piccinini, F., Simoni, M., & Brigante, G. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00775-3
Biondi, B. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.61-65
“Some hypothyroid patients (especially athyreotic patients) have higher serum free T 4 and lower T 3 levels than euthyroid controls, even when they have adequate replacement with L-T 4 monotherapy (13,14).”
Appropriate management for patients with cytologically Bethesda indeterminate thyroid nodules
García-Mayor, R. V. (2021) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2021.09.00299
AKDENİZ, D. D., & Öztop, M. B. (2021) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.916680 · Cited by 2
“Some of them found low levels of T3 (15, 16) but there are also studies demonstrated normal t3 levels in a patient who are on LT4 therapy (17,18).”
BackgroundEXTENDED ABSORPTION OF LIOTHYRONINE FROM POLY-ZINC-LIOTHYRONINE (PZL) IN HUMANSPreprint
Dumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M. D., Giurcanu, M. C., & Bianco, A. C. (2021) · medRxiv · doi:10.1101/2021.06.14.21258437
“First noticed around 1974 (6), subsequent studies revealed that LT4-treated patients maintain a ∼10% lower serum T3 levels (7,8).”
BackgroundThe pharmacological management of hypothyroidism
Moolman, L. J. (2021) · South African General Practitioner · doi:10.36303/sagp.2021.2.2.0070
Hypothyroidism - A Causal Approach to Testing Assumptions against Empirical Results.
Glavin, R., Ness, R. O., & Nguyen, A. (2021) · PubMed
Pasión e identidad: el problema del conocimiento en el "De anima" de Aristóteles
Martín, J. I. A. S. (1999) · Dialnet (Universidad de la Rioja)
(2021) · The Egyptian Journal of Community Medicine · doi:10.21608/ejcm.2021.202265 · Cited by 1
Newman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1 · Cited by 1
(2020) · The Annals of Family Medicine · doi:10.1370/afm.2581
7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
New-Onset Heart Failure in the Setting of T4-Conversion Disorder
Chan, N. I., Pak, K., Guo, A., Singla, P., & Sayegh, M. N. (2022) · Cureus · doi:10.7759/cureus.25024 · Cited by 1
“There is a possibility that these individuals have abnormal or heterogeneity in deiodinase activity, which was addressed after giving combined therapy [16].”
BackgroundShames, R., & Wenzel, S. (2022) · Journal of Restorative Medicine · doi:10.14200/jrm.2022.0002 · Cited by 1
Fatigue and Quality of Life in Patients with Papillary Thyroid Carcinoma Postoperatively
Ito, M., & Akamizu, T. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.504-506
QUALITY OF LIFE OF PATIENTS WITH POSTOPERATIVE HYPOTHYROID AND HASHIMOTO THYROIDITIS
FELEK, D., & Duman, G. (2023) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.1209398 · Cited by 1
Ito, M., & Akamizu, T. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.402-404
Ipotiroidismo clinico in corso di terapia sostitutiva con l-tiroxina
Trimarchi, A., & Castagna, M. G. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01386-4
Abd‐ElGawad, M., Abdelgalil, M. S., Abdelsattar, N. K., Salamah, H. M., & Kamel, M. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3542960/v1
Terapia dell’ipotiroidismo primitivo: un ormone o due ormoni?
Brigante, G., Ceccarini, G., Porcelli, T., Santini, F., Salvatore, D., Simoni, M., & Bartalena, L. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01429-4
“Circa il 30% dei pazienti ipotiroidei in monoterapia con L-T4 presenta un rapporto T3/T4 plasmatico ridotto rispetto ai controlli eutiroidei nonostante valori di TSH normali [4, 12].”
Thyroid and Parathyroid Transplantation
Sakr, M. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-64102-2_18
Brigante, G. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01585-1
Special Considerations in the Treatment of Hypothyroidism
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_12
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_11
Hypothalamic–Pituitary–Thyroid Regulation
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_5
Dai, D., Qiao, Y., Zhang, B., Wang, Y., Zhao, M., & Huang, J. (2025) · Medicine · doi:10.1097/md.0000000000043843 · Cited by 1
“17–19] Additionally, persistent circulating thyroid autoantibodies may contribute to vestibulocochlear dysfunction via immune-mediated pathways.”
Pharmacological Interactions of Levothyroxine in Multiple-Treated Patients
Marco, F. D., & Cusini, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_14
Lasheen, N. N., Shawky, S., Gaber, N., & Mohamed, A. E.-H. A. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1606528 · Cited by 1
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2024) · Figshare · doi:10.6084/m9.figshare.26613242
Larsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt‐Rasmussen, U., Groenvold, M., Bjorner, J. B., Hegedüs, L., Watt, T., & Bonnema, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26614339
Ito, M., Furumura, Y., Monno, I., Deguchi-Horiuchi, H., Imamura, C., Takahashi, S., Yamaoka, H., Hisakado, M., Kohsaka, K., Nishihara, E., et al. (2026) · Thyroid Research · doi:10.1186/s13044-026-00300-y
Nagayama, Y., Tachibana, S., Fukuda, T., Tatsushima, D., Mori, Y., Shindo, H., Takahashi, H., Satoh, S., Nakashima, M., & Yamashita, H. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag220
Ingle, R. G., & Sonwane, G. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1843556
“Separate data suggest that at any given time, roughly half of all patients on L-T4 have TSH values outside the optimal range (24).”
Ohba, K., & Goto, Y. (2026) · Thyroid Science · doi:10.1016/j.thscie.2026.100048
Metadata
- Authors
- Gullo, D., Latina, A., Frasca, F., Le Moli, R., Pellegriti, G., & Vigneri, R.
- Affiliations
- University of Catania (IT)
- Corresponding author
- Gullo, Damiano
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-01
- Volume
- 6
- Issue
- 8
- Pages
- e22552
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3148220
- OpenAlex
- W2163820892
- Cited by
- 307
- References
- 32
- Citations by year
- 2026: 14 · 2025: 25 · 2024: 20 · 2023: 26 · 2022: 27 · 2021: 25 · 2020: 31 · 2019: 30 · 2018: 20 · 2017: 18 · 2016: 20 · 2015: 18 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Università di Catania
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- levothyroxine monotherapy, athyreosis, hypothyroidism, free triiodothyronine, free thyroxine, T3/T4 ratio, thyroid-stimulating hormone, euthyroidism
- MeSH terms
- Humans, Hypothyroidism, Immunoenzyme Techniques, Retrospective Studies, Thyroid Hormones, Thyrotropin, Thyroxine, Case-Control Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.